CN1253589A - 来自肺炎链球菌的降解人类补体c3的蛋白酶 - Google Patents

来自肺炎链球菌的降解人类补体c3的蛋白酶 Download PDF

Info

Publication number: CN1253589A
Authority: CN; China
Prior art keywords: protein; streptococcus pneumoniae; nucleic acid; antibody; seq
Prior art date: 1997-04-24
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Pending

Application number

CN98804470A

Other languages

English (en)

Chinese (zh)

Inventor

马格列特·K·霍斯泰特

盖瑞·唐尼

拉克施米·S·南狄瓦答

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

University of Minnesota

Original Assignee

University of Minnesota

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-04-24

Filing date

1998-04-24

Publication date

2000-05-17

1998-04-24 Application filed by University of Minnesota filed Critical University of Minnesota

2000-05-17 Publication of CN1253589A publication Critical patent/CN1253589A/zh

Status Pending legal-status Critical Current

Links

230000000295 complement effect Effects 0.000 title claims abstract description 17
241000193998 Streptococcus pneumoniae Species 0.000 title claims description 126
229940031000 streptococcus pneumoniae Drugs 0.000 title claims description 121
108091005804 Peptidases Proteins 0.000 title abstract description 40
102000035195 Peptidases Human genes 0.000 title abstract description 36
235000019833 protease Nutrition 0.000 title abstract 4
125000003275 alpha amino acid group Chemical group 0.000 claims abstract 2
108090000623 proteins and genes Proteins 0.000 claims description 187
235000018102 proteins Nutrition 0.000 claims description 154
102000004169 proteins and genes Human genes 0.000 claims description 154
210000004027 cell Anatomy 0.000 claims description 68
230000008859 change Effects 0.000 claims description 54
150000007523 nucleic acids Chemical group 0.000 claims description 52
150000001413 amino acids Chemical class 0.000 claims description 41
108020004414 DNA Proteins 0.000 claims description 39
239000012634 fragment Substances 0.000 claims description 39
241000894006 Bacteria Species 0.000 claims description 38
238000000034 method Methods 0.000 claims description 38
108090000765 processed proteins & peptides Proteins 0.000 claims description 36
235000001014 amino acid Nutrition 0.000 claims description 30
108020004707 nucleic acids Proteins 0.000 claims description 29
102000039446 nucleic acids Human genes 0.000 claims description 29
238000009396 hybridization Methods 0.000 claims description 26
230000015556 catabolic process Effects 0.000 claims description 19
238000006731 degradation reaction Methods 0.000 claims description 19
230000004936 stimulating effect Effects 0.000 claims description 19
102000000989 Complement System Proteins Human genes 0.000 claims description 17
108010069112 Complement System Proteins Proteins 0.000 claims description 17
239000000470 constituent Substances 0.000 claims description 17
101000901154 Homo sapiens Complement C3 Proteins 0.000 claims description 16
229920001184 polypeptide Polymers 0.000 claims description 12
102000004196 processed proteins & peptides Human genes 0.000 claims description 12
238000006062 fragmentation reaction Methods 0.000 claims description 11
210000000987 immune system Anatomy 0.000 claims description 11
229960000856 protein c Drugs 0.000 claims description 10
239000002253 acid Substances 0.000 claims description 9
241000972773 Aulopiformes Species 0.000 claims description 8
108091028043 Nucleic acid sequence Proteins 0.000 claims description 8
102000007056 Recombinant Fusion Proteins Human genes 0.000 claims description 8
108010008281 Recombinant Fusion Proteins Proteins 0.000 claims description 8
238000003780 insertion Methods 0.000 claims description 8
230000037431 insertion Effects 0.000 claims description 8
239000002773 nucleotide Substances 0.000 claims description 8
125000003729 nucleotide group Chemical group 0.000 claims description 8
235000019515 salmon Nutrition 0.000 claims description 8
238000004140 cleaning Methods 0.000 claims description 7
241001465754 Metazoa Species 0.000 claims description 6
230000028993 immune response Effects 0.000 claims description 6
102000008394 Immunoglobulin Fragments Human genes 0.000 claims description 4
108010021625 Immunoglobulin Fragments Proteins 0.000 claims description 4
241000283973 Oryctolagus cuniculus Species 0.000 claims description 4
210000003719 b-lymphocyte Anatomy 0.000 claims description 3
210000003527 eukaryotic cell Anatomy 0.000 claims description 3
230000005867 T cell response Effects 0.000 claims description 2
230000036755 cellular response Effects 0.000 claims description 2
150000003951 lactams Chemical class 0.000 claims 2
229920002554 vinyl polymer Polymers 0.000 claims 2
241000124008 Mammalia Species 0.000 claims 1
229920002401 polyacrylamide Polymers 0.000 abstract description 6
210000002706 plastid Anatomy 0.000 description 74
239000000499 gel Substances 0.000 description 32
239000000523 sample Substances 0.000 description 30
230000008521 reorganization Effects 0.000 description 29
239000013256 coordination polymer Substances 0.000 description 27
229940024606 amino acid Drugs 0.000 description 24
230000000694 effects Effects 0.000 description 23
241000588724 Escherichia coli Species 0.000 description 22
230000000968 intestinal effect Effects 0.000 description 20
ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 description 18
238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 18
101150010653 cppA gene Proteins 0.000 description 15
239000000243 solution Substances 0.000 description 13
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 12
230000001580 bacterial effect Effects 0.000 description 12
208000015181 infectious disease Diseases 0.000 description 12
238000012360 testing method Methods 0.000 description 12
229960005486 vaccine Drugs 0.000 description 12
206010037211 Psychomotor hyperactivity Diseases 0.000 description 11
238000005516 engineering process Methods 0.000 description 11
PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 10
DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 10
238000011160 research Methods 0.000 description 10
238000002965 ELISA Methods 0.000 description 9
102000004190 Enzymes Human genes 0.000 description 9
108090000790 Enzymes Proteins 0.000 description 9
101100007585 Neisseria gonorrhoeae cppA gene Proteins 0.000 description 9
238000005520 cutting process Methods 0.000 description 9
229940088598 enzyme Drugs 0.000 description 9
229960003276 erythromycin Drugs 0.000 description 9
108010040473 pneumococcal surface protein A Proteins 0.000 description 9
229920001817 Agar Polymers 0.000 description 8
KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 8
PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 8
239000013611 chromosomal DNA Substances 0.000 description 8
239000000203 mixture Substances 0.000 description 8
238000012163 sequencing technique Methods 0.000 description 8
LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 8
108020004705 Codon Proteins 0.000 description 7
101000779242 Severe acute respiratory syndrome coronavirus 2 ORF3a protein Proteins 0.000 description 7
239000007983 Tris buffer Substances 0.000 description 7
238000013016 damping Methods 0.000 description 7
238000002474 experimental method Methods 0.000 description 7
239000000284 extract Substances 0.000 description 7
239000012530 fluid Substances 0.000 description 7
239000012528 membrane Substances 0.000 description 7
238000000926 separation method Methods 0.000 description 7
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 6
OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
201000005010 Streptococcus pneumonia Diseases 0.000 description 6
239000008272 agar Substances 0.000 description 6
238000004458 analytical method Methods 0.000 description 6
230000008485 antagonism Effects 0.000 description 6
238000006243 chemical reaction Methods 0.000 description 6
230000000593 degrading effect Effects 0.000 description 6
238000001962 electrophoresis Methods 0.000 description 6
230000003287 optical effect Effects 0.000 description 6
238000002360 preparation method Methods 0.000 description 6
239000000047 product Substances 0.000 description 6
239000011780 sodium chloride Substances 0.000 description 6
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
DWNBOPVKNPVNQG-LURJTMIESA-N (2s)-4-hydroxy-2-(propylamino)butanoic acid Chemical compound CCCN[C@H](C(O)=O)CCO DWNBOPVKNPVNQG-LURJTMIESA-N 0.000 description 5
ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 5
HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 5
OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 5
101710125418 Major capsid protein Proteins 0.000 description 5
108700026244 Open Reading Frames Proteins 0.000 description 5
ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 5
230000005540 biological transmission Effects 0.000 description 5
235000011187 glycerol Nutrition 0.000 description 5
HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 5
239000013642 negative control Substances 0.000 description 5
235000015097 nutrients Nutrition 0.000 description 5
230000009467 reduction Effects 0.000 description 5
230000010076 replication Effects 0.000 description 5
239000013605 shuttle vector Substances 0.000 description 5
238000001228 spectrum Methods 0.000 description 5
206010057248 Cell death Diseases 0.000 description 4
HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
239000004471 Glycine Substances 0.000 description 4
XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 4
DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 4
WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 4
COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 4
229920001213 Polysorbate 20 Polymers 0.000 description 4
239000004365 Protease Substances 0.000 description 4
102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 4
AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 4
230000003321 amplification Effects 0.000 description 4
WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 4
230000009089 cytolysis Effects 0.000 description 4
238000004520 electroporation Methods 0.000 description 4
238000011156 evaluation Methods 0.000 description 4
230000036039 immunity Effects 0.000 description 4
230000002163 immunogen Effects 0.000 description 4
230000035772 mutation Effects 0.000 description 4
238000003199 nucleic acid amplification method Methods 0.000 description 4
239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 4
235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 4
235000019419 proteases Nutrition 0.000 description 4
230000006798 recombination Effects 0.000 description 4
238000005215 recombination Methods 0.000 description 4
230000002829 reductive effect Effects 0.000 description 4
230000001373 regressive effect Effects 0.000 description 4
108091008146 restriction endonucleases Proteins 0.000 description 4
OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 4
YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 3
QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 3
101710131943 40S ribosomal protein S3a Proteins 0.000 description 3
239000004475 Arginine Substances 0.000 description 3
102100022133 Complement C3 Human genes 0.000 description 3
QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 3
ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 description 3
CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 3
FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 3
108010052285 Membrane Proteins Proteins 0.000 description 3
101710163270 Nuclease Proteins 0.000 description 3
241001494479 Pecora Species 0.000 description 3
206010035664 Pneumonia Diseases 0.000 description 3
MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 3
102400000368 Surface protein Human genes 0.000 description 3
AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 3
239000004473 Threonine Substances 0.000 description 3
ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 3
235000009697 arginine Nutrition 0.000 description 3
230000015572 biosynthetic process Effects 0.000 description 3
239000000969 carrier Substances 0.000 description 3
210000002421 cell wall Anatomy 0.000 description 3
239000003153 chemical reaction reagent Substances 0.000 description 3
229960001231 choline Drugs 0.000 description 3
OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 3
KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
238000000502 dialysis Methods 0.000 description 3
238000013467 fragmentation Methods 0.000 description 3
150000004676 glycans Chemical class 0.000 description 3
230000012010 growth Effects 0.000 description 3
230000006872 improvement Effects 0.000 description 3
230000002779 inactivation Effects 0.000 description 3
230000001939 inductive effect Effects 0.000 description 3
229910052943 magnesium sulfate Inorganic materials 0.000 description 3
235000019341 magnesium sulphate Nutrition 0.000 description 3
229960004452 methionine Drugs 0.000 description 3
238000002156 mixing Methods 0.000 description 3
229910052759 nickel Inorganic materials 0.000 description 3
229940049547 paraxin Drugs 0.000 description 3
230000001717 pathogenic effect Effects 0.000 description 3
239000008188 pellet Substances 0.000 description 3
COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 3
229920001282 polysaccharide Polymers 0.000 description 3
239000005017 polysaccharide Substances 0.000 description 3
229920000136 polysorbate Polymers 0.000 description 3
230000006641 stabilisation Effects 0.000 description 3
238000011105 stabilization Methods 0.000 description 3
238000003860 storage Methods 0.000 description 3
239000006228 supernatant Substances 0.000 description 3
239000013598 vector Substances 0.000 description 3
KDELTXNPUXUBMU-UHFFFAOYSA-N 2-[2-[bis(carboxymethyl)amino]ethyl-(carboxymethyl)amino]acetic acid boric acid Chemical compound OB(O)O.OB(O)O.OB(O)O.OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KDELTXNPUXUBMU-UHFFFAOYSA-N 0.000 description 2
201000001178 Bacterial Pneumonia Diseases 0.000 description 2
101150071258 C3 gene Proteins 0.000 description 2
AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 2
238000001712 DNA sequencing Methods 0.000 description 2
108010054576 Deoxyribonuclease EcoRI Proteins 0.000 description 2
241000224432 Entamoeba histolytica Species 0.000 description 2
206010018364 Glomerulonephritis Diseases 0.000 description 2
WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 2
108010003272 Hyaluronate lyase Proteins 0.000 description 2
102000001974 Hyaluronidases Human genes 0.000 description 2
MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 2
QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 2
102000008192 Lactoglobulins Human genes 0.000 description 2
108010060630 Lactoglobulins Proteins 0.000 description 2
KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 2
108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 2
DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 2
239000000020 Nitrocellulose Substances 0.000 description 2
239000004677 Nylon Substances 0.000 description 2
229930182555 Penicillin Natural products 0.000 description 2
JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 2
ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
239000002202 Polyethylene glycol Substances 0.000 description 2
241000589517 Pseudomonas aeruginosa Species 0.000 description 2
RADKZDMFGJYCBB-UHFFFAOYSA-N Pyridoxal Chemical compound CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 2
101000702488 Rattus norvegicus High affinity cationic amino acid transporter 1 Proteins 0.000 description 2
229920002684 Sepharose Polymers 0.000 description 2
239000013504 Triton X-100 Substances 0.000 description 2
229920004890 Triton X-100 Polymers 0.000 description 2
QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 2
KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 2
241000700605 Viruses Species 0.000 description 2
YVNQAIFQFWTPLQ-UHFFFAOYSA-O [4-[[4-(4-ethoxyanilino)phenyl]-[4-[ethyl-[(3-sulfophenyl)methyl]amino]-2-methylphenyl]methylidene]-3-methylcyclohexa-2,5-dien-1-ylidene]-ethyl-[(3-sulfophenyl)methyl]azanium Chemical compound C1=CC(OCC)=CC=C1NC1=CC=C(C(=C2C(=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S(O)(=O)=O)C)C=2C(=CC(=CC=2)N(CC)CC=2C=C(C=CC=2)S(O)(=O)=O)C)C=C1 YVNQAIFQFWTPLQ-UHFFFAOYSA-O 0.000 description 2
238000004026 adhesive bonding Methods 0.000 description 2
239000002671 adjuvant Substances 0.000 description 2
210000001552 airway epithelial cell Anatomy 0.000 description 2
-1 amido benzene Chemical compound 0.000 description 2
238000000137 annealing Methods 0.000 description 2
239000000427 antigen Substances 0.000 description 2
108091007433 antigens Proteins 0.000 description 2
102000036639 antigens Human genes 0.000 description 2
230000033228 biological regulation Effects 0.000 description 2
AIYUHDOJVYHVIT-UHFFFAOYSA-M caesium chloride Chemical compound [Cl-].[Cs+] AIYUHDOJVYHVIT-UHFFFAOYSA-M 0.000 description 2
210000000349 chromosome Anatomy 0.000 description 2
NKLPQNGYXWVELD-UHFFFAOYSA-M coomassie brilliant blue Chemical compound [Na+].C1=CC(OCC)=CC=C1NC1=CC=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C=CC(=CC=2)N(CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=C1 NKLPQNGYXWVELD-UHFFFAOYSA-M 0.000 description 2
230000007812 deficiency Effects 0.000 description 2
238000011161 development Methods 0.000 description 2
230000018109 developmental process Effects 0.000 description 2
238000010586 diagram Methods 0.000 description 2
238000010790 dilution Methods 0.000 description 2
239000012895 dilution Substances 0.000 description 2
201000010099 disease Diseases 0.000 description 2
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 2
229910000397 disodium phosphate Inorganic materials 0.000 description 2
235000019800 disodium phosphate Nutrition 0.000 description 2
230000005611 electricity Effects 0.000 description 2
238000010828 elution Methods 0.000 description 2
229940007078 entamoeba histolytica Drugs 0.000 description 2
238000009585 enzyme analysis Methods 0.000 description 2
229960005542 ethidium bromide Drugs 0.000 description 2
238000000605 extraction Methods 0.000 description 2
230000008014 freezing Effects 0.000 description 2
238000007710 freezing Methods 0.000 description 2
102000057770 human C3 Human genes 0.000 description 2
229960002773 hyaluronidase Drugs 0.000 description 2
230000001900 immune effect Effects 0.000 description 2
BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 2
229930027917 kanamycin Natural products 0.000 description 2
229960000318 kanamycin Drugs 0.000 description 2
SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 2
229930182823 kanamycin A Natural products 0.000 description 2
239000007788 liquid Substances 0.000 description 2
210000003712 lysosome Anatomy 0.000 description 2
230000001868 lysosomic effect Effects 0.000 description 2
239000003550 marker Substances 0.000 description 2
230000001404 mediated effect Effects 0.000 description 2
239000002609 medium Substances 0.000 description 2
229930182817 methionine Natural products 0.000 description 2
238000005497 microtitration Methods 0.000 description 2
UHOVQNZJYSORNB-UHFFFAOYSA-N monobenzene Natural products C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 2
229920001220 nitrocellulos Polymers 0.000 description 2
229920001778 nylon Polymers 0.000 description 2
230000014207 opsonization Effects 0.000 description 2
235000019161 pantothenic acid Nutrition 0.000 description 2
244000052769 pathogen Species 0.000 description 2
229940049954 penicillin Drugs 0.000 description 2
230000000737 periodic effect Effects 0.000 description 2
229920001223 polyethylene glycol Polymers 0.000 description 2
229940031937 polysaccharide vaccine Drugs 0.000 description 2
238000004321 preservation Methods 0.000 description 2
230000002265 prevention Effects 0.000 description 2
230000017854 proteolysis Effects 0.000 description 2
239000002516 radical scavenger Substances 0.000 description 2
239000011541 reaction mixture Substances 0.000 description 2
229960002477 riboflavin Drugs 0.000 description 2
235000019192 riboflavin Nutrition 0.000 description 2
239000002151 riboflavin Substances 0.000 description 2
238000012882 sequential analysis Methods 0.000 description 2
235000020183 skimmed milk Nutrition 0.000 description 2
239000000126 substance Substances 0.000 description 2
238000002560 therapeutic procedure Methods 0.000 description 2
238000012546 transfer Methods 0.000 description 2
238000010023 transfer printing Methods 0.000 description 2
229960004799 tryptophan Drugs 0.000 description 2
210000005239 tubule Anatomy 0.000 description 2
238000002689 xenotransplantation Methods 0.000 description 2
XRDUNZCLSCKAMY-BXRBKJIMSA-N (2s)-2,4-bis(azanyl)-4-oxidanylidene-butanoic acid Chemical compound OC(=O)[C@@H](N)CC(N)=O.OC(=O)[C@@H](N)CC(N)=O XRDUNZCLSCKAMY-BXRBKJIMSA-N 0.000 description 1
HOZBSSWDEKVXNO-BXRBKJIMSA-N (2s)-2-azanylbutanedioic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O.OC(=O)[C@@H](N)CC(O)=O HOZBSSWDEKVXNO-BXRBKJIMSA-N 0.000 description 1
GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 1
108091032973 (ribonucleotides)n+m Proteins 0.000 description 1
FLUZBADEVUCQAE-UHFFFAOYSA-N 1-sulfanylethanol 2-sulfanylethanol Chemical compound CC(O)S.OCCS FLUZBADEVUCQAE-UHFFFAOYSA-N 0.000 description 1
IBAOFQIOOBQLHE-UHFFFAOYSA-N 2-amino-3,9-dihydropurin-9-ium-6-one;chloride Chemical compound Cl.N1C(N)=NC(=O)C2=C1N=CN2 IBAOFQIOOBQLHE-UHFFFAOYSA-N 0.000 description 1
DAQHMCWYXJEOCG-UHFFFAOYSA-N 2-oxopropanoic acid;sodium Chemical compound [Na].CC(=O)C(O)=O DAQHMCWYXJEOCG-UHFFFAOYSA-N 0.000 description 1
NKDFYOWSKOHCCO-YPVLXUMRSA-N 20-hydroxyecdysone Chemical compound C1[C@@H](O)[C@@H](O)C[C@]2(C)[C@@H](CC[C@@]3([C@@H]([C@@](C)(O)[C@H](O)CCC(C)(O)C)CC[C@]33O)C)C3=CC(=O)[C@@H]21 NKDFYOWSKOHCCO-YPVLXUMRSA-N 0.000 description 1
QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
108010013043 Acetylesterase Proteins 0.000 description 1
108010043137 Actomyosin Proteins 0.000 description 1
108010088751 Albumins Proteins 0.000 description 1
102000009027 Albumins Human genes 0.000 description 1
NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 1
241000486679 Antitype Species 0.000 description 1
208000035404 Autolysis Diseases 0.000 description 1
108091003079 Bovine Serum Albumin Proteins 0.000 description 1
UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
208000003643 Callosities Diseases 0.000 description 1
102000003846 Carbonic anhydrases Human genes 0.000 description 1
108090000209 Carbonic anhydrases Proteins 0.000 description 1
229930186147 Cephalosporin Natural products 0.000 description 1
108010028780 Complement C3 Proteins 0.000 description 1
102000016918 Complement C3 Human genes 0.000 description 1
102100031725 Cortactin-binding protein 2 Human genes 0.000 description 1
230000004544 DNA amplification Effects 0.000 description 1
238000007400 DNA extraction Methods 0.000 description 1
241001269238 Data Species 0.000 description 1
108010067770 Endopeptidase K Proteins 0.000 description 1
QTANTQQOYSUMLC-UHFFFAOYSA-O Ethidium cation Chemical compound C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 QTANTQQOYSUMLC-UHFFFAOYSA-O 0.000 description 1
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
101000833492 Homo sapiens Jouberin Proteins 0.000 description 1
101000651236 Homo sapiens NCK-interacting protein with SH3 domain Proteins 0.000 description 1
206010020649 Hyperkeratosis Diseases 0.000 description 1
102100024407 Jouberin Human genes 0.000 description 1
FFEARJCKVFRZRR-UHFFFAOYSA-N L-Methionine Natural products CSCCC(N)C(O)=O FFEARJCKVFRZRR-UHFFFAOYSA-N 0.000 description 1
229930064664 L-arginine Natural products 0.000 description 1
235000014852 L-arginine Nutrition 0.000 description 1
150000008537 L-aspartic acids Chemical class 0.000 description 1
IFQSXNOEEPCSLW-DKWTVANSSA-N L-cysteine hydrochloride Chemical compound Cl.SC[C@H](N)C(O)=O IFQSXNOEEPCSLW-DKWTVANSSA-N 0.000 description 1
150000008542 L-histidines Chemical class 0.000 description 1
229930195722 L-methionine Natural products 0.000 description 1
KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
102000003960 Ligases Human genes 0.000 description 1
108090000364 Ligases Proteins 0.000 description 1
108060008487 Myosin Proteins 0.000 description 1
102000003505 Myosin Human genes 0.000 description 1
LHAVJMWIUUIOPK-MENMJLHVSA-N N[C@@H](CCCCN)C(=O)O.C(CC)N[C@@H](CCO)C(=O)O Chemical compound N[C@@H](CCCCN)C(=O)O.C(CC)N[C@@H](CCO)C(=O)O LHAVJMWIUUIOPK-MENMJLHVSA-N 0.000 description 1
102000005348 Neuraminidase Human genes 0.000 description 1
108010006232 Neuraminidase Proteins 0.000 description 1
PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 1
101150073872 ORF3 gene Proteins 0.000 description 1
108091034117 Oligonucleotide Proteins 0.000 description 1
208000005141 Otitis Diseases 0.000 description 1
241000609499 Palicourea Species 0.000 description 1
101710099976 Photosystem I P700 chlorophyll a apoprotein A1 Proteins 0.000 description 1
208000035109 Pneumococcal Infections Diseases 0.000 description 1
101710183389 Pneumolysin Proteins 0.000 description 1
101710159752 Poly(3-hydroxyalkanoate) polymerase subunit PhaE Proteins 0.000 description 1
108010076039 Polyproteins Proteins 0.000 description 1
101710130262 Probable Vpr-like protein Proteins 0.000 description 1
101710197985 Probable protein Rev Proteins 0.000 description 1
101800004937 Protein C Proteins 0.000 description 1
102000017975 Protein C Human genes 0.000 description 1
108010076504 Protein Sorting Signals Proteins 0.000 description 1
LCTONWCANYUPML-UHFFFAOYSA-M Pyruvate Chemical compound CC(=O)C([O-])=O LCTONWCANYUPML-UHFFFAOYSA-M 0.000 description 1
108020005091 Replication Origin Proteins 0.000 description 1
208000018569 Respiratory Tract disease Diseases 0.000 description 1
206010057190 Respiratory tract infections Diseases 0.000 description 1
108010083644 Ribonucleases Proteins 0.000 description 1
102000006382 Ribonucleases Human genes 0.000 description 1
240000004808 Saccharomyces cerevisiae Species 0.000 description 1
101800001700 Saposin-D Proteins 0.000 description 1
108091058545 Secretory proteins Proteins 0.000 description 1
102000040739 Secretory proteins Human genes 0.000 description 1
238000002105 Southern blotting Methods 0.000 description 1
241000589970 Spirochaetales Species 0.000 description 1
241000194017 Streptococcus Species 0.000 description 1
QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 1
210000001744 T-lymphocyte Anatomy 0.000 description 1
108020005038 Terminator Codon Proteins 0.000 description 1
JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 1
206010044565 Tremor Diseases 0.000 description 1
239000006035 Tryptophane Substances 0.000 description 1
108060008682 Tumor Necrosis Factor Proteins 0.000 description 1
102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 description 1
241000251539 Vertebrata <Metazoa> Species 0.000 description 1
229930003756 Vitamin B7 Natural products 0.000 description 1
208000027418 Wounds and injury Diseases 0.000 description 1
150000008065 acid anhydrides Chemical class 0.000 description 1
150000007513 acids Chemical class 0.000 description 1
230000009471 action Effects 0.000 description 1
230000004913 activation Effects 0.000 description 1
125000002252 acyl group Chemical group 0.000 description 1
239000011543 agarose gel Substances 0.000 description 1
235000004279 alanine Nutrition 0.000 description 1
150000001299 aldehydes Chemical class 0.000 description 1
229910000147 aluminium phosphate Inorganic materials 0.000 description 1
235000019270 ammonium chloride Nutrition 0.000 description 1
238000010171 animal model Methods 0.000 description 1
230000005875 antibody response Effects 0.000 description 1
229960001230 asparagine Drugs 0.000 description 1
235000003704 aspartic acid Nutrition 0.000 description 1
229960005261 aspartic acid Drugs 0.000 description 1
235000021028 berry Nutrition 0.000 description 1
OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
229960002685 biotin Drugs 0.000 description 1
235000020958 biotin Nutrition 0.000 description 1
239000011616 biotin Substances 0.000 description 1
230000037396 body weight Effects 0.000 description 1
229940098773 bovine serum albumin Drugs 0.000 description 1
239000012267 brine Substances 0.000 description 1
UDSAIICHUKSCKT-UHFFFAOYSA-N bromophenol blue Chemical compound C1=C(Br)C(O)=C(Br)C=C1C1(C=2C=C(Br)C(O)=C(Br)C=2)C2=CC=CC=C2S(=O)(=O)O1 UDSAIICHUKSCKT-UHFFFAOYSA-N 0.000 description 1
239000007853 buffer solution Substances 0.000 description 1
239000001110 calcium chloride Substances 0.000 description 1
235000011148 calcium chloride Nutrition 0.000 description 1
229910001628 calcium chloride Inorganic materials 0.000 description 1
238000003763 carbonization Methods 0.000 description 1
239000003054 catalyst Substances 0.000 description 1
238000004113 cell culture Methods 0.000 description 1
230000001413 cellular effect Effects 0.000 description 1
229940124587 cephalosporin Drugs 0.000 description 1
150000001780 cephalosporins Chemical class 0.000 description 1
UCKZMPLVLCKKMO-LHLIQPBNSA-N cephamycin Chemical compound S1CC(C)=C(C(O)=O)N2C(=O)[C@@H](C)[C@]21OC UCKZMPLVLCKKMO-LHLIQPBNSA-N 0.000 description 1
238000004587 chromatography analysis Methods 0.000 description 1
230000001149 cognitive effect Effects 0.000 description 1
230000003750 conditioning effect Effects 0.000 description 1
238000010276 construction Methods 0.000 description 1
239000013068 control sample Substances 0.000 description 1
235000018417 cysteine Nutrition 0.000 description 1
XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
SUYVUBYJARFZHO-RRKCRQDMSA-N dATP Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-RRKCRQDMSA-N 0.000 description 1
SUYVUBYJARFZHO-UHFFFAOYSA-N dATP Natural products C1=NC=2C(N)=NC=NC=2N1C1CC(O)C(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-UHFFFAOYSA-N 0.000 description 1
230000006378 damage Effects 0.000 description 1
230000034994 death Effects 0.000 description 1
238000000354 decomposition reaction Methods 0.000 description 1
230000007123 defense Effects 0.000 description 1
230000002950 deficient Effects 0.000 description 1
230000008021 deposition Effects 0.000 description 1
230000001066 destructive effect Effects 0.000 description 1
239000003085 diluting agent Substances 0.000 description 1
230000008034 disappearance Effects 0.000 description 1
239000012153 distilled water Substances 0.000 description 1
239000003814 drug Substances 0.000 description 1
239000000975 dye Substances 0.000 description 1
208000019258 ear infection Diseases 0.000 description 1
ZMMJGEGLRURXTF-UHFFFAOYSA-N ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 description 1
239000008103 glucose Substances 0.000 description 1
229960002989 glutamic acid Drugs 0.000 description 1
ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
230000011132 hemopoiesis Effects 0.000 description 1
208000013403 hyperactivity Diseases 0.000 description 1
208000008384 ileus Diseases 0.000 description 1
230000003053 immunization Effects 0.000 description 1
238000002649 immunization Methods 0.000 description 1
238000003018 immunoassay Methods 0.000 description 1
230000005847 immunogenicity Effects 0.000 description 1
230000001976 improved effect Effects 0.000 description 1
230000006698 induction Effects 0.000 description 1
230000028709 inflammatory response Effects 0.000 description 1
208000014674 injury Diseases 0.000 description 1
238000011081 inoculation Methods 0.000 description 1
230000003993 interaction Effects 0.000 description 1
SURQXAFEQWPFPV-UHFFFAOYSA-L iron(2+) sulfate heptahydrate Chemical compound O.O.O.O.O.O.O.[Fe+2].[O-]S([O-])(=O)=O SURQXAFEQWPFPV-UHFFFAOYSA-L 0.000 description 1
238000005304 joining Methods 0.000 description 1
UJKDYMOBUGTJLZ-RUCXOUQFSA-N ksc605q1h Chemical compound OC(=O)[C@@H](N)CCC(O)=O.OC(=O)[C@@H](N)CCC(O)=O UJKDYMOBUGTJLZ-RUCXOUQFSA-N 0.000 description 1
238000002372 labelling Methods 0.000 description 1
210000002429 large intestine Anatomy 0.000 description 1
239000012160 loading buffer Substances 0.000 description 1
HWYHZTIRURJOHG-UHFFFAOYSA-N luminol Chemical compound O=C1NNC(=O)C2=C1C(N)=CC=C2 HWYHZTIRURJOHG-UHFFFAOYSA-N 0.000 description 1
239000006166 lysate Substances 0.000 description 1
239000000155 melt Substances 0.000 description 1
239000002184 metal Substances 0.000 description 1
229910052751 metal Inorganic materials 0.000 description 1
239000013586 microbial product Substances 0.000 description 1
238000010369 molecular cloning Methods 0.000 description 1
238000012544 monitoring process Methods 0.000 description 1
150000004682 monohydrates Chemical class 0.000 description 1
230000001537 neural effect Effects 0.000 description 1
230000007935 neutral effect Effects 0.000 description 1
229960003966 nicotinamide Drugs 0.000 description 1
235000005152 nicotinamide Nutrition 0.000 description 1
239000011570 nicotinamide Substances 0.000 description 1
239000006916 nutrient agar Substances 0.000 description 1
150000004987 o-phenylenediamines Chemical class 0.000 description 1
230000001662 opsonic effect Effects 0.000 description 1
229940014662 pantothenate Drugs 0.000 description 1
239000011713 pantothenic acid Substances 0.000 description 1
230000008506 pathogenesis Effects 0.000 description 1
210000001539 phagocyte Anatomy 0.000 description 1
239000008055 phosphate buffer solution Substances 0.000 description 1
238000002264 polyacrylamide gel electrophoresis Methods 0.000 description 1
239000000843 powder Substances 0.000 description 1
125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
238000012545 processing Methods 0.000 description 1
230000001737 promoting effect Effects 0.000 description 1
108020001775 protein parts Proteins 0.000 description 1
229960003581 pyridoxal Drugs 0.000 description 1
235000008164 pyridoxal Nutrition 0.000 description 1
239000011674 pyridoxal Substances 0.000 description 1
230000005855 radiation Effects 0.000 description 1
230000009257 reactivity Effects 0.000 description 1
230000000717 retained effect Effects 0.000 description 1
239000012266 salt solution Substances 0.000 description 1
239000012723 sample buffer Substances 0.000 description 1
238000012216 screening Methods 0.000 description 1
230000028327 secretion Effects 0.000 description 1
238000004062 sedimentation Methods 0.000 description 1
239000006152 selective media Substances 0.000 description 1
230000028043 self proteolysis Effects 0.000 description 1
238000010008 shearing Methods 0.000 description 1
230000035939 shock Effects 0.000 description 1
239000011734 sodium Substances 0.000 description 1
HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 1
230000007928 solubilization Effects 0.000 description 1
238000005063 solubilization Methods 0.000 description 1
238000001179 sorption measurement Methods 0.000 description 1
125000006850 spacer group Chemical group 0.000 description 1
210000000438 stratum basale Anatomy 0.000 description 1
238000006467 substitution reaction Methods 0.000 description 1
235000011149 sulphuric acid Nutrition 0.000 description 1
239000000725 suspension Substances 0.000 description 1
230000009885 systemic effect Effects 0.000 description 1
238000005382 thermal cycling Methods 0.000 description 1
235000019157 thiamine Nutrition 0.000 description 1
KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 1
229960003495 thiamine Drugs 0.000 description 1
239000011721 thiamine Substances 0.000 description 1
231100000331 toxic Toxicity 0.000 description 1
230000002588 toxic effect Effects 0.000 description 1
PIEPQKCYPFFYMG-UHFFFAOYSA-N tris acetate Chemical compound CC(O)=O.OCC(N)(CO)CO PIEPQKCYPFFYMG-UHFFFAOYSA-N 0.000 description 1
230000007306 turnover Effects 0.000 description 1
238000002604 ultrasonography Methods 0.000 description 1
239000004474 valine Substances 0.000 description 1
238000012795 verification Methods 0.000 description 1
235000013343 vitamin Nutrition 0.000 description 1
239000011782 vitamin Substances 0.000 description 1
229940088594 vitamin Drugs 0.000 description 1
229930003231 vitamin Natural products 0.000 description 1
239000011735 vitamin B7 Substances 0.000 description 1
235000011912 vitamin B7 Nutrition 0.000 description 1
150000003722 vitamin derivatives Chemical class 0.000 description 1
238000005406 washing Methods 0.000 description 1
238000001262 western blot Methods 0.000 description 1

Images

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/52—Genes encoding for enzymes or proenzymes
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/52—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Genetics & Genomics (AREA)
Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Organic Chemistry (AREA)
Zoology (AREA)
Wood Science & Technology (AREA)
Biomedical Technology (AREA)
General Engineering & Computer Science (AREA)
Biotechnology (AREA)
Immunology (AREA)
General Health & Medical Sciences (AREA)
Molecular Biology (AREA)
Biochemistry (AREA)
Microbiology (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Plant Pathology (AREA)
Veterinary Medicine (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Physics & Mathematics (AREA)
Biophysics (AREA)
Pharmacology & Pharmacy (AREA)
Peptides Or Proteins (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Enzymes And Modification Thereof (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

CN98804470A 1997-04-24 1998-04-24 来自肺炎链球菌的降解人类补体c3的蛋白酶 Pending CN1253589A (zh)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US4431697P	1997-04-24	1997-04-24
US60/044,316		1997-04-24

Publications (1)

Publication Number	Publication Date
CN1253589A true CN1253589A (zh)	2000-05-17

Family

ID=21931691

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CN98804470A Pending CN1253589A (zh)	1997-04-24	1998-04-24	来自肺炎链球菌的降解人类补体c3的蛋白酶

Country Status (8)

Country	Link
EP (1)	EP0977872A1 (pt)
JP (1)	JP2001523960A (pt)
KR (1)	KR100544594B1 (pt)
CN (1)	CN1253589A (pt)
AU (1)	AU740153B2 (pt)
BR (1)	BR9809405A (pt)
CA (1)	CA2283755A1 (pt)
WO (1)	WO1998048022A1 (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6676943B1 (en)	1997-04-24	2004-01-13	Regents Of The University Of Minnesota	Human complement C3-degrading protein from Streptococcus pneumoniae
KR20010024299A (ko) *	1997-09-24	2001-03-26	리전츠 오브 더 유니버스티 오브 미네소타	스트렙토코쿠스 뉴모니애로부터의 사람 보체 ｃ3 분해단백질분해효소
IL142017A0 (en) *	1998-09-24	2002-03-10	Univ Minnesota	Human complement c3-degrading polypeptide from streptococcus pneumoniae

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU5194598A (en) *	1996-10-31	1998-05-22	Human Genome Sciences, Inc.	(streptococcus pneumoniae) antigens and vaccines

1998
- 1998-04-24 AU AU71566/98A patent/AU740153B2/en not_active Ceased
- 1998-04-24 WO PCT/US1998/008281 patent/WO1998048022A1/en active IP Right Grant
- 1998-04-24 JP JP54636198A patent/JP2001523960A/ja not_active Ceased
- 1998-04-24 KR KR1019997009773A patent/KR100544594B1/ko not_active IP Right Cessation
- 1998-04-24 CN CN98804470A patent/CN1253589A/zh active Pending
- 1998-04-24 CA CA002283755A patent/CA2283755A1/en not_active Abandoned
- 1998-04-24 BR BR9809405-0A patent/BR9809405A/pt not_active Application Discontinuation
- 1998-04-24 EP EP98918689A patent/EP0977872A1/en not_active Ceased

Also Published As

Publication number	Publication date
AU7156698A (en)	1998-11-13
KR100544594B1 (ko)	2006-01-24
WO1998048022A1 (en)	1998-10-29
CA2283755A1 (en)	1998-10-29
EP0977872A1 (en)	2000-02-09
BR9809405A (pt)	2000-06-13
WO1998048022A9 (en)	1999-04-15
JP2001523960A (ja)	2001-11-27
KR20010012096A (ko)	2001-02-15
AU740153B2 (en)	2001-11-01

Publication	Publication Date	Title
CN1059214C (zh)	2000-12-06	纤维素结合区域
CN1352691A (zh)	2002-06-05	来自肺炎链球菌的人补体c3降解性多肽
Feng et al.	2009	Streptococcus suis enolase functions as a protective antigen displayed on the bacterial cell surface
Franco et al.	1997	Cloning and characterization of the Bacteroides fragilis metalloprotease toxin gene
CN1291233A (zh)	2001-04-11	来自肺炎链球菌之人类补体c3降解蛋白酶
CN1067679A (zh)	1993-01-06	重组dna衍生的霍乱毒素亚基类似物
CN1055024C (zh)	2000-08-02	胸膜肺炎放线杆菌亚单元疫苗
CN1541263A (zh)	2004-10-27	将AcmA型蛋白质锚融合体与微生物细胞壁材料进行结合的改良方法
JP2008067707A (ja)	2008-03-27	分類不可能なハエモフィルスインフルエンザエのｌｋｐピリン構造遺伝子およびオペロン
CN1020857C (zh)	1993-05-26	相应于轮状病毒的主要中和蛋白质的抗原和免疫决定子的肽
JP3066339B2 (ja)	2000-07-17	インフルエンザ菌用ワクチンおよび診断法
CN1181761A (zh)	1998-05-13	抗支原体的抗原组合物
Cameron et al.	1994	Identification and characterization of a putative serine protease expressed in vivo by Mycobacterium avium subsp. paratuberculosis
Old et al.	1971	Antigens of the type-2 fimbriae of salmonellae:“cross-reacting material”(CRM) of type-1 fimbriae
CN1313150C (zh)	2007-05-02	自身免疫疾病的治疗剂
KR100366482B1 (ko)	2003-08-02	백신으로서 정제된 분류가능하지 않은 헤모필루스 인프루엔자 p5단백질, 및 그의 정제방법
JPH10505752A (ja)	1998-06-09	システイン・プロテアーゼあるいはその断片を含む連鎖球菌を識別するための方法および組成物
CN1240001A (zh)	1999-12-29	链球菌毒素c突变体及其使用方法
CN1253589A (zh)	2000-05-17	来自肺炎链球菌的降解人类补体c3的蛋白酶
CN1112356A (zh)	1995-11-22	新型的减毒铜绿假单胞菌菌株
Singh et al.	2010	Molecular heterogeneity of plpE gene in Indian isolates of Pasteurella multocida and expression of recombinant PlpE in vaccine strain of P. multocida serotype B: 2
Pilehchian et al.	2011	Fusion of Clostridium perfringens type D and B epsilon and beta toxin genes and it’s cloning in E. coli
US6676943B1 (en)	2004-01-13	Human complement C3-degrading protein from Streptococcus pneumoniae
Kotel’nikova et al.	2013	Protective properties of recombinant IgA1 protease from meningococcus
RU2085586C1 (ru)	1997-07-27	Полипептид 1106, предназначенный для определения антител к вирусу иммунодефицита человека первого типа, фрагмент днк н 1106, кодирующий полипептид 1106, рекомбинантная плазмидная днк рн 1106, кодирующая полипептид 1106, штамм бактерий escherichia coli - продуцент полипептида 1106

Legal Events

Date	Code	Title
2000-05-17	C06	Publication
2000-05-17	PB01	Publication
2000-07-19	C10	Entry into substantive examination
2000-07-19	SE01	Entry into force of request for substantive examination
2010-01-13	C12	Rejection of a patent application after its publication
2010-01-13	RJ01	Rejection of invention patent application after publication